EPISODE · Jan 14, 2026 · 5 MIN
Iofina CEO: 2025 revenue to exceed $65m on record iodine output, with more to come
from Proactive - Interviews for investors · host Proactive Investors
Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker talked with Proactive's Stephen Gunnion about the company's record 2025 performance and strategic growth plans heading into 2026. The company posted a 17% increase in iodine production year-on-year, achieving double-digit growth across the fourth quarter, second half, and full year. Dr Becker attributed the strong performance to operational discipline, reinvestment into the business, and the commitment of Iofina's employees and partners. "Iofina was pretty good in 2025," Becker said, highlighting production of 743 metric tons of crystalline iodine, up from 634 metric tons the previous year. The company expects to exceed market expectations with projected revenue of over $65 million and EBITDA above $11 million. Becker emphasised that the uplift is volume-driven, with iodine pricing remaining steady in a tight range for the last three years. Demand for both raw iodine and iodine derivatives remained strong, with Iofina's global customer base growing steadily. Looking ahead, Iofina is scaling its operations with a new iodine plant under construction in the Permian Basin. The facility, expected online in the second half of 2025, will be the largest in the company's portfolio, capable of producing between 170 and 220 metric tons annually. This expansion is being funded primarily through internal cash flows with minimal debt. For more exclusive interviews and updates, head to Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for the latest content. #Iofina #TomBecker #IodineProduction #AIMStocks #OTCMarkets #ChemicalIndustry #PermianBasin #EBITDA #RevenueGrowth #CrystallineIodine #InvestingInCommodities #ProactiveInvestors
What this episode covers
Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker talked with Proactive's Stephen Gunnion about the company's record 2025 performance and strategic growth plans heading into 2026. The company posted a 17% increase in iodine production year-on-year, achieving double-digit growth across the fourth quarter, second half, and full year. Dr Becker attributed the strong performance to operational discipline, reinvestment into the business, and the commitment of Iofina's employees and partners. "Iofina was pretty good in 2025," Becker said, highlighting production of 743 metric tons of crystalline iodine, up from 634 metric tons the previous year. The company expects to exceed market expectations with projected revenue of over $65 million and EBITDA above $11 million. Becker emphasised that the uplift is volume-driven, with iodine pricing remaining steady in a tight range for the last three years. Demand for both raw iodine and iodine derivatives remained strong, with Iofina's global customer base growing steadily. Looking ahead, Iofina is scaling its operations with a new iodine plant under construction in the Permian Basin. The facility, expected online in the second half of 2025, will be the largest in the company's portfolio, capable of producing between 170 and 220 metric tons annually. This expansion is being funded primarily through internal cash flows with minimal debt. For more exclusive interviews and updates, head to Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for the latest content. #Iofina #TomBecker #IodineProduction #AIMStocks #OTCMarkets #ChemicalIndustry #PermianBasin #EBITDA #RevenueGrowth #CrystallineIodine #InvestingInCommodities #ProactiveInvestors
NOW PLAYING
Iofina CEO: 2025 revenue to exceed $65m on record iodine output, with more to come
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.